How Cannabis Treats Chronic Back Pain
Chronic back pain involves multiple mechanisms: nociceptive pain (from tissue damage), neuropathic pain (from nerve compression), and central sensitisation (amplified pain signalling). Cannabis addresses all three mechanisms. THC activates CB1 receptors in the spinal cord's dorsal horn, suppressing pain signal transmission. CBD modulates TRPV1 channels implicated in neuropathic back pain and reduces neuroinflammation. The terpene myrcene contributes muscle-relaxant properties that address back pain from muscle spasm. OG Kush and Blue Dream are among the most reported strains for back pain. See the complete pain relief effects guide for strain and dosing recommendations.
Clinical Evidence & Research
The 2017 National Academies of Sciences report found conclusive evidence that cannabis is effective for chronic pain in adults — the strongest quality designation applied to any cannabis indication. Multiple observational studies of medical cannabis patients with back pain show 50-60% pain reduction over 12 months. A landmark study found that in states with medical cannabis access, opioid overdose deaths were 25% lower. A 2022 survey of 3,000+ chronic back pain patients found cannabis users reported significantly better pain scores, sleep quality, and functional capacity than non-users. Germany approved medical cannabis for chronic pain including back pain in 2017.
Access & Patient Requirements
Chronic back pain qualifies patients in 40+ US medical cannabis states — the broadest acceptance of any single pain condition. Documentation typically requires: pain duration of 3+ months, imaging or diagnostic evidence of structural pathology (herniated disc, spinal stenosis, degenerative disc disease), and ideally prior opioid prescriptions or failed conventional treatments. California, Colorado, and New York all have straightforward back pain qualification pathways. Many patients obtain cards within 2-4 weeks of initial consultation.
Recommended Cannabis Approaches for Back Pain
Topical cannabis preparations (creams, balms) provide targeted relief for localised lower back pain without systemic effects and are safe for daily use. Oral CBD (25-75mg daily) maintains anti-inflammatory tone and reduces central sensitisation over time. Higher-THC preparations are appropriate for acute flares and night use when pain disrupts sleep. Vaporised cannabis provides rapid 2-5 minute onset for breakthrough pain. Anti-inflammatory effects address the root inflammation driving many back pain conditions. CBD combined with the beta-caryophyllene terpene provides a particularly potent anti-inflammatory combination for back pain with an inflammatory component.